Sanofi and GlaxoSmithKline announced the initiation of a new phase 2 study to select the most appropriate antigen dosage for…
Trending
- FAAN confirms fire at MMIA terminal 2
- NMA Zamfara inaugurates new executives
- Stakeholders urge minister to retract ODL remarks
- UNICEF: Breastfeeding key to building healthy society
- DRC Bundibugyo outbreak becomes largest Ebola crisis
- Vet konect graduates first women in poultry cohort
- Catfish farming gains popularity in Dutse
- NADF, NBS sign MoU to improve agricultural data
